-
Mike J. Finney, Ph.D.
Dr. Finney has served as a member of Vaxart’s board of directors since July 2007 and as Chief Executive Officer from 2009 to 2011. Since October 2004, Dr. Finney has served as the Managing Director of Finney Capital, a venture capital firm, and from 1986, he has served as a founder, director, and/or investor…
-
Steven Lo
Mr. Lo is a highly experienced biopharma executive with over 25 years of experience in the healthcare, biotechnology, and pharmaceutical industries, including over 12 years of C-level experience in publicly traded biotech companies. Prior to Vaxart, Mr. Lo was Chief Executive Officer and a member of the board of directors of Valitor, a private biotech…
-
Kevin Finney
Mr. Finney currently serves as President and Chief Executive Officer of Autobahn Therapeutics and Chairman of its Board of Directors since 2019. Prior to joining Autobahn, Mr. Finney served as President, Chief Operating Officer, and a Director of Abide Therapeutics through the company’s acquisition by Lundbeck in 2019. Prior to this, Mr. Finney founded and served as the Chief Operating…
-
Elaine J. Heron, Ph.D.
Dr. Heron currently serves on the boards of BioMarin Pharmaceutical, Inc., a leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases, Palvella Therapeutics, Inc., a private clinical-stage therapeutics company, Visgenx, Inc., a private early-stage therapeutics company, and Watershed Medical, Inc., a private early-stage therapeutics company. Dr. Heron also serves as an…
-
W. Mark Watson
Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing, having spent his entire career from January 1973 to June 2013 at Deloitte Touche Tohmatsu and its predecessor, most recently as Central Florida Marketplace Leader. He has served as lead audit partner and lead client service partner…
-
David Wheadon, M. D.
Dr. Wheadon is a former senior executive of AstraZeneca Plc, having recently retired as senior Vice-President (SVP), Global Regulatory Affairs, Patient Safety and Quality Assurance. He joined the board of Vaxart in April 2021. Dr. Wheadon has had a long and distinguished career in the healthcare sector in senior leadership positions, including: Executive VP, Research…
